Cumberland Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$345K Sell
850
-33,573
-98% -$13.6M 0.02% 159
2025
Q1
$17.1M Sell
34,423
-272
-0.8% -$135K 1.32% 24
2024
Q4
$18M Sell
34,695
-73
-0.2% -$38K 1.26% 25
2024
Q3
$21.5M Sell
34,768
-14,600
-30% -$9.03M 1.49% 22
2024
Q2
$27.3M Sell
49,368
-1,369
-3% -$757K 1.99% 18
2024
Q1
$29.5M Buy
50,737
+877
+2% +$510K 2.14% 18
2023
Q4
$25.3M Sell
49,860
-745
-1% -$378K 2.31% 17
2023
Q3
$25.6M Sell
50,605
-1,213
-2% -$614K 2.46% 17
2023
Q2
$27M Sell
51,818
-715
-1% -$373K 2.48% 15
2023
Q1
$30.3M Sell
52,533
-922
-2% -$531K 2.97% 9
2022
Q4
$29.4M Sell
53,455
-4,022
-7% -$2.21M 3.1% 9
2022
Q3
$29.2M Buy
57,477
+2,080
+4% +$1.05M 3.1% 8
2022
Q2
$30.1M Sell
55,397
-3,333
-6% -$1.81M 2.87% 10
2022
Q1
$34.7M Buy
58,730
+95
+0.2% +$56.1K 2.62% 11
2021
Q4
$39.1M Buy
58,635
+2,415
+4% +$1.61M 2.75% 7
2021
Q3
$32.1M Buy
56,220
+794
+1% +$454K 2.63% 8
2021
Q2
$28M Sell
55,426
-3,918
-7% -$1.98M 2.19% 10
2021
Q1
$27.1M Sell
59,344
-1,023
-2% -$467K 2.23% 12
2020
Q4
$28.1M Sell
60,367
-1,214
-2% -$565K 2.52% 10
2020
Q3
$27.2M Buy
61,581
+1,363
+2% +$602K 2.84% 9
2020
Q2
$21.8M Buy
60,218
+2,657
+5% +$963K 2.26% 12
2020
Q1
$16.3M Sell
57,561
-2,343
-4% -$664K 1.96% 17
2019
Q4
$19.5M Buy
59,904
+403
+0.7% +$131K 1.73% 20
2019
Q3
$17.3M Buy
59,501
+18,335
+45% +$5.34M 1.67% 23
2019
Q2
$12.1M Buy
+41,166
New +$12.1M 1.16% 28